AIG
SRNE

American International Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

American International Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-218,199
Closed -$193K – 3011
2022
Q4 		$193K Buy
218,199
+37,694
+21% +$50K ﹤0.01% 2145
2022
Q3 		$283K Buy
180,505
+2,550
+1% +$5.78K ﹤0.01% 1939
2022
Q2 		$358K Buy
177,955
+29,634
+20% +$51.2K ﹤0.01% 1814
2022
Q1 		$346K Sell
148,321
-10,439
-7% -$32.6K ﹤0.01% 1927
2021
Q4 		$738K Buy
158,760
+6,699
+4% +$41.6K ﹤0.01% 1590
2021
Q3 		$1.16M Sell
152,061
-705
-0.5% -$5.98K 0.01% 1361
2021
Q2 		$1.48M Buy
152,766
+6,887
+5% +$54.8K 0.01% 1290
2021
Q1 		$1.21M Buy
145,879
+385
+0.3% +$4.07K ﹤0.01% 1361
2020
Q4 		$993K Buy
145,494
+13,128
+10% +$105K ﹤0.01% 1385
2020
Q3 		$1.48M Buy
132,366
+25,119
+23% +$230K 0.01% 1068
2020
Q2 		$674K Buy
107,247
+30,096
+39% +$115K ﹤0.01% 1435
2020
Q1 		$142K Sell
77,151
-1,195
-2% -$3.44K ﹤0.01% 2108
2019
Q4 		$265K Sell
78,346
-659
-0.8% -$1.57K ﹤0.01% 2044
2019
Q3 		$169K Buy
79,005
+4,626
+6% +$10.8K ﹤0.01% 2288
2019
Q2 		$199K Buy
74,379
+1,353
+2% +$4.87K ﹤0.01% 2238
2019
Q1 		$347K Buy
73,026
+1,050
+1% +$2.75K ﹤0.01% 1909
2018
Q4 		$173K Sell
71,976
-554
-0.8% -$1.81K ﹤0.01% 2266
2018
Q3 		$319K Buy
72,530
+15,895
+28% +$88.1K ﹤0.01% 2145
2018
Q2 		$408K Buy
+56,635
New +$385K ﹤0.01% 1967
2017
Q2 		– Sell
-17,532
Closed -$69K – 3140
2017
Q1 		$69K Buy
17,532
+1,030
+6% +$5.17K ﹤0.01% 2752
2016
Q4 		$81K Sell
16,502
-44
-0.3% -$264 ﹤0.01% 2718
2016
Q3 		$128K Buy
16,546
+25
+0.2% +$168 ﹤0.01% 2465
2016
Q2 		$92.5K Sell
16,521
-92
-0.6% -$588 ﹤0.01% 2665
2016
Q1 		$89K Hold
16,613
– – ﹤0.01% 3518
2015
Q4 		$145K Sell
16,613
-29
-0.2% -$245 ﹤0.01% 3157
2015
Q3 		$140K Sell
16,642
-2,181
-12% -$34.7K ﹤0.01% 3152
2015
Q2 		$332K Buy
+18,823
New +$242K ﹤0.01% 2553

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

American International Group's SRNE Position: Q1 2023 in Review

American International Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 218,199 shares — an estimated $193K sold.

American International Group first reported a position in SRNE in Q2 2015 and held it in 27 quarters. The position peaked at $1.48M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • American International Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • American International Group sold 218,199 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $193K.
  • American International Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 27 quarters.
  • American International Group's Sorrento Therapeutics, Inc. position peaked at $1.48M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on American International Group's 13F filing for Q1 2023, filed 12 May 2023.